Evidence
Theranostics. 2024 Feb 25;14(5):2075-2098. doi: 10.7150/thno.93919. eCollection 2024.
ABSTRACT
Obesity-related metabolic diseases, including obesity, diabetes, hyperlipidemia, and non-alcoholic fatty liver diseases pose a significant threat to health. However, comprehensive pathogenesis exploration and effective therapy development are impeded by the limited availability of human models. Notably, advances in organoid technology enable the generation of adipose organoids that recapitulate structures and functions of native human adipose tissues to investigate mechanisms and develop corresponding treatments for obesity-related metabolic diseases. Here, we review the general principles, sources, and three-dimensional techniques for engineering adipose organoids, along with strategies to promote maturation. We also outline the application of white adipose organoids, primarily for disease modeling and drug screening, and highlight the therapeutic potential of thermogenic beige and brown adipose organoids in promoting weight loss and glucose and lipid metabolic homeostasis. We also discuss the challenges and prospects in the establishment and bench-to-bedside of adipose organoids, as well as their potential applications.
PMID:38505622 | PMC:PMC10945346 | DOI:10.7150/thno.93919
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Unleashing the potential of adipose organoids: A revolutionary approach to combat obesity-related metabolic diseases
🌐 90 Days
VR Related Evidence Matrix
- Generation and characterization of mature hepatocyte organoids for liver metabolic studies
- Kaempferol efficacy in metabolic diseases: Molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis
- Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases
- Adiposity, immunity, and inflammation: interrelationships in health and disease: A report from 24th annual Harvard nutrition obesity symposium, June 2023
- Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review)
- The natural compounds, Magnolol or Honokiol, promote adipose tissue browning and resist obesity through modulating PPARα/γ activity
- trans-Palmitoleic acid promotes adipose thermogenesis to reduce obesity via hypothalamic FFAR1 signaling
- Pro- and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases)
- MAFLD as part of systemic metabolic dysregulation
- MAFLD as part of systemic metabolic dysregulation
- White Adipose Tissue in Metabolic Associated Fatty Liver Disease
- Bone Marrow Adipose Tissue
- Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
- Epigenetic/circadian clocks and PCOS
- A population-based prospective study on obesity-related non-communicable diseases in northern Iran: rationale, study design, and baseline analysis
- A population-based prospective study on obesity-related non-communicable diseases in northern Iran: rationale, study design, and baseline analysis
- Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies
- SIRT1 Serum Concentrations in Lipodystrophic Syndromes
- Exposure to per- and polyfluoroalkyl substance and metabolic syndrome: A nationally representative cross-sectional study from NHANES, 2003-2018
- Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases
- Evaluation of the Diagnostic Utility of Selected Serum Adipokines and Cytokines in Subjects with MASLD-A Pilot Study
- Generation of human cerebral organoids with a structured outer subventricular zone
- Epidemiology, screening, and Co-management of type 2 diabetes mellitus and Metabolic-dysfunction associated steatotic liver disease
- Lipidomic Analysis of Liver and Adipose Tissue in a High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice Model Reveals Alterations in Lipid Metabolism by Weight Loss and Aerobic Exercise
- Organoid bioinks: construction and application
- Human cytomegalovirus (CMV) dysregulates neurodevelopmental pathways in cerebral organoids
- Influence of glucagon-like peptide-1 receptor agonists on fat accumulation in patients with diabetes mellitus and non-alcoholic fatty liver disease or obesity: A systematic review and meta-analysis of randomized control trials
- Role of the angiopoietin-like protein family in the progression of NAFLD
- Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia
- Inflammatory liver diseases and susceptibility to sepsis
- Chrononutrition in the Prevention and Management of Metabolic Disorders: A Literature Review
- The advent of RNA-based therapeutics for metabolic syndrome and associated conditions: a comprehensive review of the literature
- Population-enriched innate immune variants may identify candidate gene targets at the intersection of cancer and cardio-metabolic disease
- Population-enriched innate immune variants may identify candidate gene targets at the intersection of cancer and cardio-metabolic disease
- Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
- Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017-2018
- Anorexigenic neuropeptides as anti-obesity and neuroprotective agents
- Punicic acid ameliorates obesity-related hyperlipidemia and fatty liver in mice via regulation of intestinal flora and lipopolysaccharide-related signaling pathways
- Anthocyanin: A Potential Phytochemical Candidate for the Amelioration of Non-Alcoholic Fatty Liver Disease
- Raman-AFM-fluorescence-guided impact of linoleic and eicosapentaenoic acids on subcellular structure and chemical composition of normal and cancer human colon cells
- A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity
- Does the liver facilitate aging-related cognitive impairment: Conversation between liver and brain during exercise?
- Pomegranate supplementation alleviates dyslipidemia and the onset of non-alcoholic fatty liver disease in Wistar rats by shifting microbiota and producing urolithin-like microbial metabolites
- The endoplasmic reticulum stress protein GRP94 modulates cathepsin L activity in M2 macrophages in conditions of obesity-associated inflammation and contributes to their pro-inflammatory profile
- Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS myelin regeneration
- Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations
- The NAD+ Precursor Nicotinamide Riboside Rescues Mitochondrial Defects and Neuronal Loss in iPSC derived Cortical Organoid of Alpers' Disease
- Blood vessel organoids generated by base editing and harboring single nucleotide variation in Notch3 effectively recapitulate CADASIL-related pathogenesis
- Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial
- Mass spectrometry imaging-based metabolomics highlights spatial metabolic alterations in three types of liver injuries
- Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
- Role of Angiotensin II in Non-Alcoholic Steatosis Development
- Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study
- Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study
- Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity
- The role of sirtuin1 in liver injury: molecular mechanisms and novel therapeutic target
- NcRNA Regulated Pyroptosis in Liver Diseases and Traditional Chinese Medicine Intervention: A Narrative Review
- Lipotoxicity: The missing link between diabetes and periodontitis?
- The attenuation of activity-based anorexia by obese adipose tissue transplant is AgRP neuron-dependent
- Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology
- Chromatin modifiers in human disease: from functional roles to regulatory mechanisms
- Exploring the role of genetic variations in NAFLD: implications for disease pathogenesis and precision medicine approaches
Evidence Blueprint
Unleashing the potential of adipose organoids: A revolutionary approach to combat obesity-related metabolic diseases
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Unleashing the potential of adipose organoids: A revolutionary approach to combat obesity-related metabolic diseases
🌐 365 Days
VR Related Evidence Matrix
- Generation and characterization of mature hepatocyte organoids for liver metabolic studies
- A Novel Drosophila Model to Investigate Adipose Tissue Macrophage Infiltration (ATM) and Obesity highlights the Therapeutic Potential of Attenuating Eiger/TNFα Signaling to Ameliorate Insulin Resistance and ATM
- Kaempferol efficacy in metabolic diseases: Molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis
- Therapeutic Activity of Green Tea Epigallocatechin-3-Gallate on Metabolic Diseases and Non-Alcoholic Fatty Liver Diseases: The Current Updates
- Adipose tissue fibrosis: the unwanted houseguest invited by obesity
- Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases
- Peripheral and central macrophages in obesity
- Adiposity, immunity, and inflammation: interrelationships in health and disease: A report from 24th annual Harvard nutrition obesity symposium, June 2023
- Gut mycobiome and metabolic diseases: The known, the unknown, and the future
- Adipose-derived extracellular vesicles - a novel cross-talk mechanism in insulin resistance, non-alcoholic fatty liver disease, and polycystic ovary syndrome
- Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity
- Brain organoids: A revolutionary tool for modeling neurological disorders and development of therapeutics
- Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases
- Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review)
- The Role of Phosphatidylethanolamine N-Methyltransferase (PEMT) and Its Waist-Hip-Ratio-Associated Locus rs4646404 in Obesity-Related Metabolic Traits and Liver Disease
- Exploring a novel therapeutic strategy: the interplay between gut microbiota and high-fat diet in the pathogenesis of metabolic disorders
- SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors
- Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies
- The natural compounds, Magnolol or Honokiol, promote adipose tissue browning and resist obesity through modulating PPARα/γ activity
- Phytochemicals for the treatment of metabolic diseases: Evidence from clinical studies
- Alcohol, White Adipose Tissue, and Brown Adipose Tissue: Mechanistic Links to Lipogenesis and Lipolysis
- trans-Palmitoleic acid promotes adipose thermogenesis to reduce obesity via hypothalamic FFAR1 signaling
- Pro- and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases)
- Multi-Organ Increase in Norepinephrine Levels after Central Leptin Administration and Diet-Induced Obesity
- Maternal obesity induced metabolic disorders in offspring and myeloid reprogramming by epigenetic regulation
- Vascularized Brain Assembloids with Enhanced Cellular Complexity Provide Insights into The Cellular Deficits of Tauopathy
- MAFLD as part of systemic metabolic dysregulation
- MAFLD as part of systemic metabolic dysregulation
- Adipose triglyceride lipase gene expression in peripheral blood mononuclear cells of subjects with obesity and its association with insulin resistance, inflammation and lipid accumulation in liver
- Therapeutic potential of oleanolic acid in liver diseases
- Metabolic complications of obesity in children and adolescents
- White Adipose Tissue in Metabolic Associated Fatty Liver Disease
- Advances in the pharmacological effects and molecular mechanisms of emodin in the treatment of metabolic diseases
- Bone Marrow Adipose Tissue
- Dose-dependent action of cordycepin on the microbiome-gut-brain-adipose axis in mice exposed to stress
- Effect of the nomenclature of non-alcoholic fatty liver disease on diagnosis and treatment of fatty liver disease concomitant with other liver diseases
- Emerging role of METTL3 in inflammatory diseases: mechanisms and therapeutic applications
- Metabolite-sensing GPCRs controlling interactions between adipose tissue and inflammation
- Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis
- Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
- Epigenetic/circadian clocks and PCOS
- A New Strategy for Obesity Treatment: Revealing the Frontiers of Anti-obesity Medications
- A population-based prospective study on obesity-related non-communicable diseases in northern Iran: rationale, study design, and baseline analysis
- A population-based prospective study on obesity-related non-communicable diseases in northern Iran: rationale, study design, and baseline analysis
- Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies
- Calcium signalling in hepatic metabolism: Health and diseases
- Cross-tissue omics analysis discovers ten adipose genes encoding secreted proteins in obesity-related non-alcoholic fatty liver disease
- Pregnane X receptor activation remodels glucose metabolism to promote NAFLD development in obese mice
- Association between metabolism-related chronic disease combination and prevalence of non-alcoholic fatty liver disease in community residents in Shanghai
- Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease
- SIRT1 Serum Concentrations in Lipodystrophic Syndromes
- Metabolic Dysfunction-Associated Steatotic Liver Disease: A State-of-the-Art Review
- Exposure to per- and polyfluoroalkyl substance and metabolic syndrome: A nationally representative cross-sectional study from NHANES, 2003-2018
- Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases
- Celastrol functions as an emerging manager of lipid metabolism: Mechanism and therapeutic potential
- OBMeta: a comprehensive web server to analyze and validate gut microbial features and biomarkers for obesity-associated metabolic diseases
- Sex- and age-specific associations between abdominal fat and non-alcoholic fatty liver disease: a prospective cohort study
- Evaluation of the Diagnostic Utility of Selected Serum Adipokines and Cytokines in Subjects with MASLD-A Pilot Study
- Sarcopenic obesity in older adults: a clinical overview
- Generation of human cerebral organoids with a structured outer subventricular zone
- Epidemiology, screening, and Co-management of type 2 diabetes mellitus and Metabolic-dysfunction associated steatotic liver disease
- Cardiovascular significance of adipose-derived adiponectin and liver-derived xanthine oxidoreductase in metabolic syndrome
- Effects of probiotics on non-alcoholic fatty liver disease: a review of human clinical trials
- Lipidomic Analysis of Liver and Adipose Tissue in a High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice Model Reveals Alterations in Lipid Metabolism by Weight Loss and Aerobic Exercise